Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda

Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis.

Saved in:
Bibliographic Details
Published in:PLoS medicine Vol. 5; no. 7; p. e150
Main Authors: Cobelens, Frank G. J, Heldal, Einar, Kimerling, Michael E, Mitnick, Carole D, Podewils, Laura J, Ramachandran, Rajeswari, Rieder, Hans L, Weyer, Karin, Zignol, Matteo
Format: Journal Article
Language:English
Published: United States Public Library of Science 01.07.2008
Public Library of Science (PLoS)
Subjects:
Antitubercular Agents - therapeutic use
Care and treatment
Case management
Clinical Trials
Drug resistance
Global Health
Guidelines and Guidance
Humans
Infectious Diseases
International Health
Medical case management
Medical research
Medicine in Developing Countries
Medicine, Experimental
Methods
Microbiology
Multidrug resistant organisms
Mycobacterium
Pilot projects
Public domain
Public Health
Public Health and Epidemiology
Science Policy
Tuberculosis
Tuberculosis, Multidrug-Resistant - drug therapy
Tuberculosis, Multidrug-Resistant - prevention & control
Tuberculosis, Multidrug-Resistant - therapy
Working groups
United States
World Health
Tuberculosis, Multidrug-Resistant
Research
Antitubercular Agents
Humans
ISSN:1549-1676, 1549-1277, 1549-1676
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Frank Cobelens and colleagues outline key research questions that need to be addressed to maximize the impact of programmatic management of drug-resistant tuberculosis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.0050150